Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
Completed · Phase 1/Phase 2
Conditions studied: Colorectal Cancer, Colon Cancer, Rectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma, Breast Cancer, Breast Neoplasms
In brief
The purpose of this trial is to determine the safety of hMN14 at different dose levels in the treatment of either colorectal or breast cancer.
Key facts
- Study ID
- NCT00041652
- Run by
- Gilead Sciences
- People needed
- 30
- Starts
- 2000-02-01
- Expected to finish
- 2003-06-01
- Last updated by the study team
- 2021-08-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Hoag Cancer Center — Newport Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.